Tradestie Institutional Equity Comparison Engine

CBLL vs PMI โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PMI Overall Edge

PMI Captures Institutional Edge (3โ€“1 Pillars ยท 4โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Picard Medical, Inc. (PMI) driven by superior Valuation, Growth & Margin, Momentum & Technical while CBLL counters with relative strength in Options & Structure. Fundamentally, CBLL trades at N/M Forward P/E with -69.8% operating margin (+29.9% YoY revenue) versus PMI at N/M Forward P/E and -248.1% operating margin (+38.6% YoY). In options structure, CBLL sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against PMI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner PMI
CBLL N/M vs PMI N/M Fwd P/E
Growth & Margin Winner PMI
Op Margin -69.8% vs -248.1% ยท YoY +29.9% vs +38.6%
Momentum & Technical Winner PMI
1Y +95.1% vs +107.2% ยท 52W Pos 81% vs 34%
Options & Structure Winner CBLL
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (N/A IV)
CBLL NASDAQ
CeriBell, Inc. Common Stock
Electromedical & Electrotherapeutic Apparatus
$25.75
+0.47% 1D
Market Cap $995.3M
1M Return -5.12%
1Y Return +95.08%
Forward P/E N/M
Unified AI Score
59.7 / 100 HOLD
Tech 51.0 Fund 50.0 Flow 50.0 Mom 50.0
PMI NYSE American
Picard Medical, Inc.
Surgical & Medical Instruments & Apparatus
$6.30
-2.17% 1D
Market Cap $17.1M
1M Return -34.58%
1Y Return +107.24%
Forward P/E N/M
Unified AI Score
48.4 / 100 HOLD
Tech 39.0 Fund 45.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CBLL +95.08% PMI +107.24% Spread: +52.95 pp (PMI Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CBLL TTM Op. Margin: -69.8% PMI TTM Op. Margin: -248.1%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CBLL vs PMI. Trailing 12-month operating profitability (CBLL -69.8% vs PMI -248.1%) and valuation multiples (CBLL N/M vs PMI N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CBLL (5) vs PMI (4)
Institutional Metric CBLL PMI Criterion Row Winner
Market Capitalization Scale $995.3M $17.1M Larger Scale CBLL
Trailing P/E Ratio Valuation N/M 2.9x Lower Multiple PMI
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +29.9% +38.6% Higher Growth PMI
Operating Margin (TTM) Profitability -69.8% -248.1% Higher Margin CBLL
Net Profit Margin Profitability -68.0% 0.0% Higher Margin PMI
Return on Equity (ROE) Capital Efficiency -52.5% 0.0% Higher ROE PMI
52-Week Range Position Momentum 81% ($13โ€“$29) 34% ($0โ€“$18) Stronger Trend CBLL
Beta / 30D Volatility Risk Regime 1.08ฮฒ ยท 41% Vol 54.06ฮฒ ยท 134% Vol Lower Realized Risk CBLL
Unified Institutional Score Composite Signal 59.7 / 100 (HOLD) 48.4 / 100 (HOLD) Higher Composite CBLL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CBLL vs PMI Buy Guide
CBLL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live CBLL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PMI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PMI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CBLL nor PMI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.